A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis
Clinical trial NCT04075266 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04075266
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-09
- Primary completion
- 2023-10-05
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.